Please login to the form below

Not currently logged in
Email:
Password:

Eisai’s Bose to join Boehringer

He becomes head of global marketing for oncology

boehringer-uday-boseBoehringer Ingelheim has named Eisai's Uday Bose as head of global marketing for its oncology business.

Taking up the role on August 1, Bose will lead marketing efforts for Boehringer's fledgling activities in cancer, which has become an increasingly important area for the company since the launch of its first oncology product Giotrif (afatinib) last year.

Since then Boehringer has also filed its second cancer product nintedanib for approval in lung cancer.

Bose's responsibilities include the long-term marketing plan for the cancer portfolio, as well as the development of global strategies for Boehringer's cancer products and guiding the launch and marketing of individual drugs.

Bose is currently head of the oncology business unit for the EMEA region at Eisai – a position he has held since 2010. His past experience include senior marketing roles at GSK's oncology business and product manager positions at Sanofi.

14th July 2014

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics